There are 594 resources available
437P - Evaluating clinico-radiological models in pulmonary nodule outcomes: Lessons from a retrospective analysis of MDT-based decisions
Presenter: Zaw Aung
Session: Poster Display session
438P - Clinical trials in thoracic oncology: Where do we come from, and where are we now?
Presenter: Benoît ALLIGNET
Session: Poster Display session
439P - Standardization of endpoints in early NSCLC randomized clinical trials (RCTs): The DATECAN initiative
Presenter: Priscilla Cascetta
Session: Poster Display session
440P - Sexual health and its impact on quality of life of patients with lung cancer
Presenter: Mafalda da Costa
Session: Poster Display session
441P - Hope for OOPE: Beyond TKI’s in treatment of NSCLC
Presenter: PATHI NIKHIL
Session: Poster Display session
Introduction
Presenter: Myung-Ju Ahn
Session: Less is more: De-escalation strategies in patient management and clinical trials
Resources:
Webcast
Less is more: De-escalation strategies in patient management and clinical trials
Presenter: Benjamin Besse
Session: Less is more: De-escalation strategies in patient management and clinical trials
Resources:
Slides
Webcast
LBA4 - Osimertinib (osi) after definitive chemoradiotherapy (CRT) in patients (pts) with unresectable (UR) stage III EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC): Updated overall survival (OS) analysis from the LAURA study
Presenter: Suresh Ramalingam
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
186O - Pembrolizumab (pembro) plus concurrent chemoradiation therapy (cCRT) in unresectable locally advanced non-small cell lung cancer (NSCLC): Final analysis of KEYNOTE-799
Presenter: Martin Reck
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
Improving screening in high-risk populations: A path to health equity
Presenter: David R. Baldwin
Session: From screening to survivorship: Building a comprehensive lung cancer continuum of care
Resources:
Slides
Webcast